Healthcare decision-making applications using multicriteria decision analysis: A scoping review

被引:48
作者
Glaize, Annabelle [1 ]
Duenas, Alejandra [2 ]
Di Martinelly, Christine [1 ]
Fagnot, Isabelle [3 ]
机构
[1] IESEG Sch Management, LEM CNRS UMR 9221, Management Dept, Lille, France
[2] CERFIGE, ICN Business Sch, Business Environm, Nancy, France
[3] Audencia Business Sch, Management Dept, Nantes, France
关键词
applications; healthcare areas; MCDA; methods; multicriteria decision analysis; scoping review; ANALYTIC HIERARCHY PROCESS; BENEFIT-RISK-ASSESSMENT; DISCRETE-CHOICE EXPERIMENT; MULTIPLE CRITERIA; ANALYSIS MCDA; TECHNOLOGY-ASSESSMENT; EVIDEM FRAMEWORK; CANCER-TREATMENT; RARE DISEASES; SELECTION;
D O I
10.1002/mcda.1659
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
The objective of this study is to review applications of multicriteria decision analysis (MCDA) methods to provide structure for and practical insights on how MCDA methods are applied in different healthcare areas. Four databases (Embase, Medline, Web of Science, and PubMed) were searched from 1980 to February 7, 2018. A scoping review was performed to outline the most frequently applied MCDA methods, in which only case studies were considered, as the objective was to assess the applications of MCDA methods. Seventy case studies were selected. The review showed that the first real-life application was published in 1990. With regard to areas of application, three aspects were analysed: type of health services (public or private), type of intervention (preventive, diagnostic, or treatment), and healthcare area (policymaking; resource allocation; health technology assessment; pharmaceutics; and hospital, clinical, or patient level). Data revealed that MCDA was principally used in public health services (n = 59). Three types of interventions were identified: prevention (n = 36), diagnosis (n = 32), and treatment (n = 2). An MCDA process of application was then followed to provide practical insights. During the problem-structuring phase, results showed that processes for selecting stakeholders and criteria differed among healthcare areas. For model building, authors preferred value measurement methods and especially the analytical hierarchy process. Authors of the 70 case studies included and confirmed the usefulness of MCDA in different healthcare contexts. The stakeholders, criteria, and MCDA methods chosen differ from one study to another, answering different research objectives in different healthcare areas. This scoping review highlights the importance of each MCDA step (using Belton and Stewart's framework), from problem structuring (including the selection of stakeholders) to the model building phase (encompassing the selection of the appropriate MCDA method). We recommend structured and justified analysis so that decision makers and stakeholders can feel confident during the application process in order to make final decisions more meaningful. Further work is needed to help researchers and decision makers when choosing a suitable MCDA method.
引用
收藏
页码:62 / 83
页数:22
相关论文
共 94 条
[31]   Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA): Applying the EVIDEM Framework to Medicines Appraisal [J].
Goetghebeur, Mireille M. ;
Wagner, Monika ;
Khoury, Hanane ;
Levitt, Randy J. ;
Erickson, Lonny J. ;
Rindress, Donna .
MEDICAL DECISION MAKING, 2012, 32 (02) :376-388
[32]   From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking [J].
Lalla Aïda Guindo ;
Monika Wagner ;
Rob Baltussen ;
Donna Rindress ;
Janine van Til ;
Paul Kind ;
Mireille M Goetghebeur .
Cost Effectiveness and Resource Allocation, 10 (1)
[33]   MULTICRITERIA DECISION ANALYSIS (MCDA) IN HTA - PILOT STUDY IN THE CZECH REPUBLIC [J].
Hajek, P. ;
Pecen, L. ;
Bulejova, L. ;
Cook, M. ;
Dolezal, T. ;
Dolezel, J. ;
Duba, J. ;
Dukova, I ;
Fuksa, L. ;
Heislerova, M. ;
Jaskova, K. ;
Karasek, P. ;
Klimes, J. ;
Kminek, A. ;
Kucera, Z. ;
Vesela, S. ;
Vothova, P. ;
Svihovec, J. .
VALUE IN HEALTH, 2014, 17 (07) :A439-A439
[34]   Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis [J].
Hsu, J. C. ;
Tang, D. H. ;
Lu, C. Y. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (04) :436-443
[35]   A SYSTEMATIC REVIEW OF THE ANALYTIC HIERARCHY PROCESS IN HEALTH CARE DECISION MAKING [J].
Hummel, J. M. ;
IJzerman, M. J. .
VALUE IN HEALTH, 2009, 12 (07) :A227-A227
[36]   Predicting the health economic performance of new non-fusion surgery in adolescent idiopathic scoliosis [J].
Hummel, J. Marjan ;
Boomkamp, Inge S. M. ;
Steuten, Lotte M. G. ;
Verkerke, Bart G. J. ;
IJzerman, Maarten J. .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2012, 30 (09) :1453-1458
[37]   Multi-criteria decision analysis for supporting the selection of medical devices under uncertainty [J].
Ivlev, Ilya ;
Vacek, Jakub ;
Kneppo, Peter .
EUROPEAN JOURNAL OF OPERATIONAL RESEARCH, 2015, 247 (01) :216-228
[38]   The role of vaccines and vaccine decision-making to achieve the goals of the Grand Convergence in public health [J].
Kaslow, David C. ;
Kalil, Jorge ;
Bloom, David ;
Breghi, Gianluca ;
Colucci, Anna Maria ;
De Gregorio, Ennio ;
Madhavan, Guru ;
Meier, Genevieve ;
Seabrook, Richard ;
Xu, Xiaoning .
VACCINE, 2017, 35 :A10-A15
[39]  
Keeney R.L., 1976, DECISIONS MULTIPLE O
[40]   Decision-making process of patients with gynecological cancer regarding their cancer treatment choices using the analytic hierarchy process [J].
Kitamura, Yuko .
JAPAN JOURNAL OF NURSING SCIENCE, 2010, 7 (02) :148-157